Syn­er­gy bags an FDA OK for con­sti­pa­tion ther­a­py Tru­lance in the lead up to an sN­DA

The FDA has hand­ed Syn­er­gy Phar­ma­ceu­ti­cals $SGYP an ap­proval for ple­ca­natide, which will now hit the mar­ket as Tru­lance for chron­ic id­io­path­ic con­sti­pa­tion.

The biotech, which has stoked ru­mors about a po­ten­tial buy­out in the re­cent past, post­ed some stel­lar da­ta from a pair of Phase III clin­i­cal tri­als for CIC and now will see if it can give Iron­wood a run for its mon­ey in of­fer­ing a ri­val to Linzess.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER